Product Information
NORG-EE 0.18-0.215-0.25/0.035 is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1268 per EA under NDC 68180083873. Its NADAC has been published 345 times since Jan 15, 2020.
FDA first approved this application on Apr 26, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180083873
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205588FDA Approved
4/26/2016
TE Code
AB
On Market Since
8/8/2019
Price Statistics
The NADAC for NORG-EE 0.18-0.215-0.25/0.035 has been published 345 times since Jan 15, 2020, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1268 per EA |
|---|---|
| All-time high | $0.2207 (Jun 10, 2020) |
| All-time low | $0.1072 (Jul 17, 2024) |
| 52-week high | $0.1375 |
| 52-week low | $0.1259 |
| Median price | $0.1418 |
| Average price | $0.1530 |
| Largest weekly change | -19.9% (Jul 17, 2024) |
| Weeks tracked | 345 |
| Tracking since | Jan 15, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORG-EE 0.18-0.215-0.25/0.035?
The current National Average Drug Acquisition Cost (NADAC) for NORG-EE 0.18-0.215-0.25/0.035, manufactured by Lupin Pharmaceuticals Inc., is $0.1268 per EA (NDC 68180083873), effective Aug 19, 2026.
How has the price of NORG-EE 0.18-0.215-0.25/0.035 changed over time?
Over the history we have for it, the NADAC for NORG-EE 0.18-0.215-0.25/0.035 has declined 36.8%. It has been tracked across 345 weekly CMS publications since Jan 15, 2020.
What are the highest and lowest recorded NADAC prices for NORG-EE 0.18-0.215-0.25/0.035?
Since Jan 15, 2020, the NADAC for NORG-EE 0.18-0.215-0.25/0.035 has ranged from a low of $0.1072 (Jul 17, 2024) to a high of $0.2207 (Jun 10, 2020), with a median of $0.1418 per EA.
Are there cheaper alternatives to NORG-EE 0.18-0.215-0.25/0.035?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESTARYLLA 0.25-0.035 MG TABLET, is $0.1190 per EA — about 6% below NORG-EE 0.18-0.215-0.25/0.035.
Who manufactures NORG-EE 0.18-0.215-0.25/0.035?
NORG-EE 0.18-0.215-0.25/0.035 (NDC 68180083873) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.